BP, Heart Rate, Arterial Stiffness Up With E-Cigarettes

Share this content:
BP, Heart Rate, Arterial Stiffness Up With E-Cigarettes
BP, Heart Rate, Arterial Stiffness Up With E-Cigarettes

TUESDAY, Sept. 12, 2017 (HealthDay News) -- Significant increases are seen in blood pressure, heart rate, and arterial stiffness in the first 30 minutes after smoking electronic-cigarettes (e-cigarettes) containing nicotine, according to a study presented at the European Respiratory Society International Congress, held from Sept. 9 to 13 in Milan.

Magnus Lundbäck, M.D., Ph.D., from the Karolinska Institute in Stockholm, and colleagues randomized 15 healthy young volunteers to 30 minutes of e-cigarette inhalation with or without nicotine in a crossover fashion. The authors measured blood pressure, heart rate, and arterial stiffness directly following exposure and at two and four hours. Pulse wave velocity and pulse wave analysis were used to measure arterial stiffness.

The researchers found that during the first 30 minutes following e-cigarette inhalation with nicotine, there was a significant increase in blood pressure, heart rate and arterial stiffness. The team did not see this effect on heart rate and arterial stiffness in the volunteers who had smoked e-cigarettes without nicotine.

"Chronic exposure to both active and passive cigarette smoking causes a permanent increase in arterial stiffness," Lundbäck said in a statement. "We speculate that chronic exposure to e-cigarettes with nicotine may cause permanent effects on arterial stiffness in the long term. As of today, there are no studies on the long-term effects on arterial stiffness following chronic e-cigarette exposure."

Press Release
More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »